Literature DB >> 29492736

Human papillomavirus vaccine: Urgent need to promote gender parity.

Cédric Abat1, Didier Raoult2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29492736     DOI： 10.1007/s10654-018-0365-0

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


× No keyword cloud information.
  12 in total

1.  Virologist wins Nobel for cervical cancer discovery.

Authors:  Stephen Pincock
Journal:  Lancet       Date:  2008-10-18       Impact factor: 79.321

2.  HPV vaccine coverage is increasing in Australia.

Authors:  Julia Ml Brotherton; Karen L Winch; Lisette Bicknell; Genevieve Chappell; Marion Saville
Journal:  Med J Aust       Date:  2017-04-03       Impact factor: 7.738

3.  Global burden of cancers attributable to infections in 2012: a synthetic analysis.

Authors:  Martyn Plummer; Catherine de Martel; Jerome Vignat; Jacques Ferlay; Freddie Bray; Silvia Franceschi
Journal:  Lancet Glob Health       Date:  2016-07-25       Impact factor: 26.763

Review 4.  EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection.

Authors:  Anna R Giuliano; Alan G Nyitray; Aimée R Kreimer; Christine M Pierce Campbell; Marc T Goodman; Staci L Sudenga; Joseph Monsonego; Silvia Franceschi
Journal:  Int J Cancer       Date:  2014-07-26       Impact factor: 7.396

Review 5.  The natural history of human papillomavirus infection.

Authors:  Silvia de Sanjosé; Maria Brotons; Miguel Angel Pavón
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2017-09-06       Impact factor: 5.237

Review 6.  Carcinogenic human papillomavirus infection.

Authors:  Mark Schiffman; John Doorbar; Nicolas Wentzensen; Silvia de Sanjosé; Carole Fakhry; Bradley J Monk; Margaret A Stanley; Silvia Franceschi
Journal:  Nat Rev Dis Primers       Date:  2016-12-01       Impact factor: 52.329

7.  Worldwide burden of cancer attributable to HPV by site, country and HPV type.

Authors:  Catherine de Martel; Martyn Plummer; Jerome Vignat; Silvia Franceschi
Journal:  Int J Cancer       Date:  2017-06-08       Impact factor: 7.396

Review 8.  Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage.

Authors:  Julia M L Brotherton; Paul N Bloem
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2017-09-06       Impact factor: 5.237

Review 9.  Human Papillomavirus Infection and Vaccination in Males.

Authors:  Eugenio Ventimiglia; Simon Horenblas; Asif Muneer; Andrea Salonia
Journal:  Eur Urol Focus       Date:  2016-09-12

10.  The use of reimbursement data for timely monitoring of vaccination coverage: the example of human papillomavirus vaccine following public concerns about vaccine safety.

Authors:  Laure Fonteneau; Marine Ragot; Isabelle Parent du Châtelet; Jean-Paul Guthmann; Daniel Lévy-Bruhl
Journal:  BMC Public Health       Date:  2015-12-12       Impact factor: 3.295
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.